Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian B S Leathart

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2006
Genotyping for cytochrome P450 polymorphismsAnn K Daly, Barry P King, Julian B S Leathart
Pancreas|June 28, 2011
Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibilityGül Özhan, Rajiv Lochan, Julian B S Leathart, et al.
Archives of Toxicology|April 2, 2003
Do multiple cytochrome P450 isoforms contribute to parathion metabolism in man?Elaine Mutch, Ann K Daly, Julian B S Leathart, et al.
British Journal of Clinical Pharmacology|June 20, 2003
CYP3A5 phenotype-genotype correlations in a British populationBarry P King, Julian B S Leathart, Elaine Mutch, et al.
Gastroenterology|January 24, 2007
Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypesAnn K Daly, Guruprasad P Aithal, Julian B S Leathart, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicityGuruprasad P Aithal, Lesley Ramsay, Ann K Daly, et al.
Journal of Hepatology|July 16, 2011
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studiesAhmad Al-Serri, Quentin M Anstee, Luca Valenti, et al.
Blood|October 20, 2011
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among childrenTina T Biss, Peter J Avery, Leonardo R Brandão, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 11, 2011
Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probesRebecca Howard, Julian B S Leathart, David J French, et al.
Journal of Hepatology|July 23, 2011
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liverLuca Valenti, Valerio Nobili, Ahmad Al-Serri, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2006
Genotyping for cytochrome P450 polymorphismsAnn K Daly, Barry P King, Julian B S Leathart
Pancreas|June 28, 2011
Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibilityGül Özhan, Rajiv Lochan, Julian B S Leathart, et al.
Archives of Toxicology|April 2, 2003
Do multiple cytochrome P450 isoforms contribute to parathion metabolism in man?Elaine Mutch, Ann K Daly, Julian B S Leathart, et al.
British Journal of Clinical Pharmacology|June 20, 2003
CYP3A5 phenotype-genotype correlations in a British populationBarry P King, Julian B S Leathart, Elaine Mutch, et al.
Gastroenterology|January 24, 2007
Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypesAnn K Daly, Guruprasad P Aithal, Julian B S Leathart, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicityGuruprasad P Aithal, Lesley Ramsay, Ann K Daly, et al.
Journal of Hepatology|July 16, 2011
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studiesAhmad Al-Serri, Quentin M Anstee, Luca Valenti, et al.
Blood|October 20, 2011
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among childrenTina T Biss, Peter J Avery, Leonardo R Brandão, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 11, 2011
Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probesRebecca Howard, Julian B S Leathart, David J French, et al.
Journal of Hepatology|July 23, 2011
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liverLuca Valenti, Valerio Nobili, Ahmad Al-Serri, et al.
Pageof 2